17 DECEMBER 2022, SATURDAY - B CONFERENCE HALL, BESIKTAS, ISTANBUL
SESSION VIII
Chairs: Bert De GROOT, Nurcan TUNÇBAĞ |
09:15-09:45 |
Kemal YELEKÇİ
Kadir Has University |
Designing of Isoform-Selective Novel Inhibitors Against Class IIA Histone Deacetylases Utilizing Molecular Modeling and In Silico Screening |
09:45-10:15 |
Mine YURTSEVER
İstanbul Technical University |
DNA Binding Simulations of Antineoplastic Drugs |
10:15-10:40 |
Serdar DURDAĞI
Bahçeşehir University |
Virtual Screening of Ultra Large Molecule Libraries Targeting Y-Box Binding Protein for Targeted Treatment of Ovarian Cancer |
10:40-11:00 |
COFFEE BREAK |
SESSION IX
Chairs: Kemal YELEKÇİ, Mine YURTSEVER |
11:00-11:30 |
Bert De GROOT
The University of Göttingen |
Relative and absolute alchemical protein-ligand binding free energies |
11:30-11:50 |
Nurcan TUNÇBAĞ
Koç University |
Network Medicine: Leveraging Integrated Connections of Multi-Omic Data |
11:50-12:10 |
Gizem DİNLER DOĞANAY
Istanbul Technical University |
Druggable peptide design and synthesis to inhibit anti-apoptotic pathways targeting critical protein-protein interactions in cancer |
12:10-12:18 |
OP-11: Öznur EYİLCİM
Yıldız Technical University |
Bioactive Drug Candidate New Molecule Synthesis |
12:18-12:26 |
OP-12: Yüksel ÇETİN
TUBITAK MAM |
Investigation of the antiviral and immunomodulatory effects of Zingiber officinale upon SARS-CoV-2 infection using in vitro airway cells culture model |
12:30-13:30 |
LUNCH |
SESSION X
Chairs: Gülşah Selin AKYÜZ, N. İpek SÖNMEZ |
13:30-14:00 |
Ahmet GÜL
İstanbul University |
Targeting Inflammasome Components for the Treatment of Autoinflammatory Disorders |
14:00-14:30 |
Erden BANOĞLU
Gazi University |
A journey from selective FLAP inhibitor to selective mPGES-1 inhibitor: A new therapeutic modality for reducing inflammation and pain |
14.30-14.38 |
OP-13: Ömer AYDIN
Erciyes University |
Delivery of Autophagy Inhibitor siRNA with "smart" Nanoparticles against Triple Negative Breast Cancer |
14.38-14.46 |
OP-14: Bengisu TURGUTALP
German Centre for Neurodegenerative Diseases |
Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer's Disease |
14.46-14.54 |
OP-15: Kaan BİRGÜL
Bahçeşehir University |
Naproxen derivatives: model compound in prostate cancer |
14.54-15.02 |
OP-16: Bahadır BÜLBÜL
Düzce University |
Asymmertric synthesis methods |
15.02-16.00 |
COFFEE BREAK |
SESSION XI
Chairs: Ahmet Emin TOPAL, Alper Devrim ÖZKAN |
16:00-16:30 |
Adil MARDİNOĞLU
King's College London |
The use of systems biology in development of drug candidates |
16:30-16:50 |
Emel TİMUÇİN
Acıbadem Mehmet Ali Aydınlar Unıversıty |
Brave New Surfactant World Revisited by Thermoalkalophilic Lipases: SDS as a Potential Substrate Analog |
16:50-16:58 |
OP-17: Lalehan OKTAY/M. Didem ORHAN
Bahçeşehir University |
Virtual Screening for Novel Small Molecule Inhibitors Against IL-17A Downstream Signaling for the Treatment of Multiple Sclerosis |
16:58-17:06 |
OP-18: Ebru Nur AY
İstinye University |
Investigation of the Effect Of TGF-ß Signaling Regulation on Cytotoxic Activity of Irinotecan in Colorectal Cancer |
17:06-17:14 |
OP-19: Ebru ÇETİN
Sabancı University |
Mechanistic View of Proglumetacin Binding to Dihydrofolate Reductase: A Drug Repurposing Study |
17:14-17:22 |
OP-20: Büşra YILDIRIM
Koç University |
Development and Characterization of Selective HDAC6 Inhibitors for the Treatment of Castration Resistant Prostate Cancer and Reversal of Taxane Resistance |
17:25-18:30 |
SHORT TALKS-II (5 minutes each) |
|
|
Short Talk-8: Gizem KURŞUNLUOĞLU |
Development of Gold Nanoparticle Conjugated Drug Delivery Systems for
Ovarian Cancer Treatment |
|
Short Talk-9: Salma GHAZY |
Virtual Screening of Small Molecule Libraries Against ERCC1-XPF for the Identification of Potent Inhibitors |
|
Short Talk-10: Serhat DÖNMEZ |
Selagibenzophenone Derivatives as novel dual Topoisomerase I/II inhibitors: In vitro biological evaluation and in silico approaches |
|
Short Talk-11: Zeynep DEMİRSOY |
NisPec stabilized gold nanospheres as a detoxifier for toxic compounds and
antimicrobial for pathogens |
|
Short Talk-12: Mısra YAMANSAVAŞÇILAR NAGANLU |
Exploring Drug Loading and Release Capacities of Hexagonal Boron Nitrides
(hBNs) in Cancer Treatment |
|
Short Talk-13: Melike BERKSÖZ |
Rational Design Strategy for a Genetically Encoded Iron Biosensor |
|
Short Talk-14: Nazar DOKUMACI |
Synthesis, Structure Elucidation and Molecular Docking Studies of Novel
Thiosemicarbazide Derivatives |
|
Short Talk-15: Faika BAŞOĞLU ÜNAL |
A novel 4-thiazolidinone derivative induces cell death in hepatocellular
carcinoma cells: in vitro assay, molecular docking, and ADME studies |
|
Short Talk-16: Malik YOUSEF |
Drug-Gene Interaction-based Pre-Existing Biological Knowledge |
|
Short Talk-17: Sahila JABRAYİLOVA |
Paclitaxel-loaded Graphene Nanocarriers with Antidot Nanoholes |
|
Short Talk-18: Miray TÜRK |
Interaction Surface of Bcl-2 and Beclin 1 was Revealed by Mass Spectrometry |
|
Short Talk-19: Gülcihan GÜLSEREN |
Development of Peptide Nanofiber Antiviral Treatment |
|
Short Talk-20: Serkan ÖNCÜOĞLU |
Synthesis of Beta-Carboline derivatives |
|
Short Talk-21: Ahmet Çağan |
Design of Tomentosin Moiety Sulfamide Derivatives and Investigation on Their Interaction with Anticancer-related Enzyme Topimerase II via In silico Approaches |
18:30-19:00 |
CLOSING CEREMONY
BEST PAPER PRESENTATIONS – BEST ORAL PRESENTATIONS AND BEST POSTER PRESENTATIONS AWARDS |